Bachem Announces Changes to the Corporate Executive Committee
Bubendorf, Switzerland--(Newsfile Corp. - May 5, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) today announced that Torsten Wöhr, Chief Commercial Officer, has decided to pursue a new opportunity outside the company. Until a successor will be appointed, Anne-Kathrin Stoller will assume the role of Chief Commercial Officer in addition to her responsibilities as Chief Executive Officer (CEO), effective May 25, 2026. “Torsten Wöhr
Biotechnologies, Produits chimiques, Soins de santé et hôpitaux, Pharmaceutique
2026-05-05 1:08 AM EDT | Bachem Holding AG
Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of various cancer, bacteria and viruses has released the Company's audited consolidated financial statements for the twelve-month period ended December 31
Technologies, Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique
2026-05-04 5:22 PM EDT | Theralase Technologies Inc.
Richards Group Inc. Announces 2026 First Quarter Results
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announced today results for the quarter ended March 31, 2026. "The first quarter of 2026 saw a few important milestones in our long-term strategic plan. We launched a series of new OEM products under the DermapenWorld brand, grew significantly across our healthcare distribution verticals, and continued packaging modernization with ecommerce fulfillment site launches and the go-live of
Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques, Pharmaceutique
2026-05-04 7:00 AM EDT | Richards Group Inc.
Richards Group Inc. Announces Election of Directors
Mississauga, Ontario--(Newsfile Corp. - May 1, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announced that the six nominees listed in the management information circular for the 2026 Annual Meeting of Shareholders were elected as Directors of the Company at the annual general meeting held in Mississauga, Ontario on May 1, 2026. Detailed results of the vote for the election of directors held at the meeting are set out below:
Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques, Pharmaceutique
2026-05-01 5:34 PM EDT | Richards Group Inc.
United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation
Gaithersburg, Maryland--(Newsfile Corp. - May 1, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts. United Dogecoin will be merged into a wholly owned subsidiary of Shuttle. The merger is supported by a $11 million concurrent Private Investment in Public Equity ("PIPE") financing expected to close on Ma
2026-05-01 8:41 AM EDT | Shuttle Pharmaceuticals Holdings Inc.
Neural Therapeutics Announces Filing and Mailing of Meeting Materials for Annual and Special Meeting to Approve Series B Transactions with CWE
Toronto, Ontario--(Newsfile Corp. - May 1, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic solutions for mental health conditions related to substance use disorders, announces that it has filed on SEDAR+ and completed the mailing of its notice of annual and special meeting, management information circular and related meeting materials (collectively, the "Mee
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-05-01 8:04 AM EDT | Neural Therapeutics Inc.
Richards Group Inc. Announces Acquisition of the CPG Assets of PharmaSystems Inc.
Toronto, Ontario--(Newsfile Corp. - April 30, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announces today an acquisition to add to its healthcare line up. Effective May 1, 2026, the Company, through its subsidiary, Healthmark Services Ltd., is acquiring the assets of PharmaSystems Inc.'s consumer packaged goods division ("PSI CPG"), a leading provider of essential over-the-counter health and wellness products to major pharmacies and retailers across Canada. The purchase pr
Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques, Pharmaceutique
2026-04-30 6:00 PM EDT | Richards Group Inc.
BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 30, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its proprietary Botanical Synthesis™ platform, today announced that it will report its first quarter 2026 financial results before the market opening on Thursday, May 14, 2026. The Company will also host a conference call and webcast at 8:00 a.m. U.S. Eastern Time to discuss the results and provide
Biotechnologies, Pharmaceutique, Santé
2026-04-30 4:05 PM EDT | BioHarvest Sciences Inc.
Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner
Gaithersburg, Maryland--(Newsfile Corp. - April 30, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts. United Dogecoin will be merged into a wholly owned subsidiary of Shuttle. The merger is supported by a $11 million concurrent Private Investment in Public Equity ("PIPE") financing expected to close on
2026-04-30 4:05 PM EDT | Shuttle Pharmaceuticals Holdings Inc.
Herbal Dispatch Completes First International Gummy Export, Generates $350,000 in Revenue and Advances Global Edibles Strategy
Vancouver, British Columbia--(Newsfile Corp. - April 30, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), today announces the successful completion of its first export of medical cannabis gummies to Australia, generating approximately $350,000 in revenue and marking a significant milestone in the Company's international growth strategy. The export reflects accelerating global demand for regulated cann
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-30 8:00 AM EDT | Herbal Dispatch Inc.
TempraMed Announces Continuance into Ontario
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that it has continued out of the provincial jurisdiction of British Columbia under the Business Corporations Act (British Columbia) into the provincial jurisdiction of Ontario under the
Technologies, Biotechnologies, Pharmaceutique, Santé
2026-04-29 4:30 PM EDT | TempraMed Technologies Ltd.
Bachem Annual General Meeting 2026
Bubendorf, Switzerland--(Newsfile Corp. - April 29, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) announced today that its Annual General Meeting 2026 has approved all proposals of the Board of Directors. A total of 78,3% of the 74‘977‘940 eligible shares were present. The Annual General Meetin
Biotechnologies, Produits chimiques, Soins de santé et hôpitaux, Pharmaceutique
2026-04-29 12:09 PM EDT | Bachem Holding AG
BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 29, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a leader in Botanical Synthesis™ technology, today announced a s
Biotechnologies, Pharmaceutique, Santé
2026-04-29 8:30 AM EDT | BioHarvest Sciences Inc.
Herbal Dispatch Provides Market Update on Launch of First Edible Brand: Chomp Edibles
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis e-commerce and distribution platform, today announced the launch of its first dedicated edibles brand, Chomp Edibles ("Chomp"), marking a strategic expansion into one of the fastest-growing segments of the Canadian cannabis market. Chomp represents a focus
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-28 3:01 AM EDT | Herbal Dispatch Inc.
InMed Pharmaceuticals Amends Preferred Investment Options
Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announces that it has entered into amending agreements in respect of preferred investment options previously entered into with each of Sabby Volatility Warrant Master Fund, Ltd.
Biotechnologies, Pharmaceutique
2026-04-27 5:30 PM EDT | InMed Pharmaceuticals
Herbal Dispatch Advances U.S. Strategy amid Historic Cannabis Rescheduling Shift
Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), provides an update on recent regulatory developments in the United States relating to the proposed rescheduling of cannabis under the Controlled Substances Act. The U.S. Department of Health and Human Services has recommended that cannabis be reclassified from Schedule I to Schedule III, a move th
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-27 3:01 AM EDT | Herbal Dispatch Inc.
Bachem Secures Financing of Strategic Growth Initiatives
Bubendorf, Switzerland--(Newsfile Corp. - April 27, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) announced today the closing of a revolving credit facility of C
Biotechnologies, Produits chimiques, Soins de santé et hôpitaux, Pharmaceutique
2026-04-27 1:03 AM EDT | Bachem Holding AG
Defence Therapeutics Announces Grant of Restricted Stock Units
Montreal, Quebec--(Newsfile Corp. - April 24, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, wishes to announce that the board of directors of the Company approved the grant of 200,000 incentive restricted stock units ("RSUs") to Mr. Sebastien Plouffe, CEO and Director of the Company, vesting immediately. Each RSU entitles the
Biotechnologies, Pharmaceutique, Santé
2026-04-24 6:30 PM EDT | Defence Therapeutics Inc.
Herbal Dispatch Reports Q4 2025 Gross Sales of $6.2 Million, Achieves Positive Adjusted EBITDA, and Reports Full Year Gross Sales of $16.5 Million
Vancouver, British Columbia--(Newsfile Corp. - April 24, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), announces its financial results for the fourth quarter and year ended December 31, 2025. Q4 2025 HIGHLIGHTS Gross sales of $6.2 million, representing a 115% increase compared to $2.9 million in Q4 2024 Net revenue of $4.1 million (excluding excise
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-24 3:01 AM EDT | Herbal Dispatch Inc.
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
King of Prussia, Pennsylvania--(Newsfile Corp. - April 23, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will provide an overview of the Company's INTASYL siRNA platform and discuss recent clinical progress and priorities,
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-04-23 7:00 AM EDT | Phio Pharmaceuticals Corp.